[1] Paré A, Joly A. Oral cancer: Risk factors and management [J]. Presse Med, 2017, 46(3):320-330. [2] Ketabat F, Pundir M, Mohabatpour F, et al. Controlled drug delivery systems for oral cancer treatment-current status and future perspectives [J]. Pharmaceutics, 2019, 11(7): 302. [3] Liu L, Chen J, Cai X, et al. Progress in targeted therapeutic drugs for oral squamous cell carcinoma [J]. Surg Oncol, 2019, 31: 90-97. [4] Montero PH, Patel SG. Cancer of the oral cavity [J]. Surg Oncol Clin N Am, 2015, 24(3):491-508. [5] Ghantous Y, Abu Elnaaj I. Global incidence and risk factors of oral cancer [J]. Harefuah, 2017, 156(10): 645-649. [6] 张瑶,张汀荣,薛蓓云.淫羊藿素对非小细胞肺癌细胞增殖、凋亡、侵袭力的影响[J].中国临床医生杂志,2018,46(6):704-707. [7] Wo YB, Zhu DY, Hu Y, et al. Reactive oxygen species involved in prenylflavonoids,icariin and icaritin,initiating cardiac differentiation of mouse embryonic stem cells [J]. J Cell Biochem, 2008, 103: 1536-1550. [8] Menon SS, Guruvayoorappan C, Sakthivel KM, et al. Ki-67 protein as a tumour proliferation marker [J]. Clin Chim Acta, 2019, 491:39-45. [9] Jing Y, Zhou Q, Zhu H, et al. Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma [J]. Oncol Lett, 2019, 17(1):974-980. [10] Deng WY, Ye SB, Luo RZ, et al. Notch-1 and Ki-67 receptor as predictors for the recurrence and prognosis of Kimura's disease [J]. Int J Clin Exp Pathol, 2014, 7(5):2402-2410. [11] 李天客,张影,张素欣,等.基于加权基因共表达网络分析挖掘舌鳞状细胞癌的关键基因[J].口腔医学研究,2020,36(5):423-427. [12] Fukusumi T, Califano JA. The NOTCH pathway in head and neck squamous cell carcinoma [J]. J Dent Res, 2018, 97(6):645-653. [13] Li Y, Li YH, Chen XX. NOTCH and esophageal squamous cell carcinoma[J]. Adv Exp Med Biol, 2021, 1287:59-68. [14] Srivastava SS, Alam H, Patil SJ, et al. Keratin 5/14-mediated cell differentiation and transformation are regulated by TAp63 and Notch-1 in oral squamous cell carcinoma-derived cells[J]. Oncol Rep, 2018, 39(5):2393-2401. [15] Kujan O, Huang G, Ravindran A, et al. CDK4,CDK6,cyclin D1 and Notch1 immunocytochemical expression of oral brush liquid-based cytology for the diagnosis of oral leukoplakia and oral cancer [J]. J Oral Pathol Med, 2019, 48(7):566-573. [16] Yoshida R, Nagata M, Nakayama H, et al. The pathological significance of Notch1 in oral squamous cell carcinoma[J]. Lab Invest, 2013, 93(10):1068-1081. [17] Porcheri C, Meisel CT, Mitsiadis T, et al. Multifactorial contribution of Notch signaling in head and neck squamous cell carcinoma[J]. Int J Mol Sci, 2019, 20(6):1520. [18] Sakamoto K, Fujii T, Kawachi H, et al. Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes insquamous neoplasms[J]. Lab Invest, 2012, 92(5):688-702. [19] Kumar M, Nanavati R, Modi TG, et al. Oral cancer: Etiology and risk factors: A review [J]. J Cancer Res Ther, 2016, 12(2):458-463. [20] Yang JG, Lu R, Ye XJ, et al. Icaritin reduces oral squamous cell carcinoma progression via the inhibition of STAT3 signaling [J]. Int J Mol Sci, 2017, 18(1):132. [21] Dholam KP, Chouksey GC. Squamous cell carcinoma of the oral cavity and oropharynx in patients aged 18-45 years: A case-control study to evaluate the risk factors with emphasis on stress,diet,oral hygiene,and family history [J]. Indian J Cancer, 2016, 53(2):244-251. [22] Jing Y, Zhou Q, Zhu H, et al. Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma [J]. Oncol Lett, 2019, 17(1):974-980. [23] Nishi H, Shinozaki T, Tomioka T, et al. Squamous cell carcinoma of the retromolar trigone: Treatment outcomes [J]. Auris Nasus Larynx, 2018, 45(2):337-342. [24] Lei K, Ma B, Shi P, et al. Icariin mitigates the growth and invasion ability of human oral squamous cell carcinoma via inhibiting Toll-like receptor 4 and phosphorylation of NF-κB p65 [J]. Onco Targets Ther, 2020, 13:299-307. [25] Xu C, Huang X, Tong Y, et al. Icariin modulates the sirtuin/NF-κB pathway and exerts anti-aging effects in human lung fibroblasts [J]. Mol Med Rep, 2020, 22(5):3833-3839. [26] Wang S, Gao J, Li Q, et al. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology [J]. J Ethnopharmacol, 2020, 262:113189. [27] Gharaibeh LF, Elmadany N, Alwosaibai K, et al. Notch 1 in cancer therapy: possible clinical implications and challenges [J]. Mol Pharmacol, 2020, 98(5):559-576. [28] Li Y, Wang Z, Jin J, et al. Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway [J]. Biochem Biophys Res Commun, 2020, 523(4):947-953. |